How Advent France tech transfer fund will apply IP commercialization model in France
By Stephen Hansen, Associate Editor | Apr 21, 2017 | 7:42 PM GMT
With the largest tech transfer fund in the country, Advent France Biotechnology is aiming to apply the academic IP commercialization model on a much larger scale than has previously been done in France.
Read the full 339 word article
User Sign In
This article may not be distributed to non-subscribers
PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD